Acid ceramidase inhibition enhances venetoclax sensitivity in preclinical models of acute myeloid leukemia

被引：0
|
作者：
Ung, Johnson
Tan, Su-Fern
Shaw, Jeremy J.
Fox, Todd E.
Taori, Maansi
Claxton, David F.
Fisher-Wellman, Kelsey H.
Cabot, Myles C.
Feith, David J.
Loughran, Thomas P.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4740
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4740
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Alvocidib Potentiates the Activity of Venetoclax in Preclinical Models of Acute Myeloid Leukemia
    Whatcott, Clifford J.
    Bogenberger, James M.
    Kim, Wontak
    Haws, Hillary
    Hansen, Nanna
    Delman, Devora
    Sproat, Lisa
    Palmer, Jeanne
    Mesa, Ruben A.
    Peterson, Peter
    Siddiqui-Jain, Adam
    Weitman, Steven
    Bearss, David J.
    Warner, Steven L.
    Tibes, Raoul
    BLOOD, 2016, 128 (22)
  • [2] Acid ceramidase inhibition: A targeted therapy for acute myeloid leukemia.
    Pearson, Jennifer M.
    Tan, Su-Fern
    Sharma, Arati
    Fox, Todd E.
    Luis Abad, Jose
    Fabrias, Gemma
    Claxton, David F.
    Feith, David J.
    Kester, Mark
    Loughran, Thomas P., Jr.
    CLINICAL CANCER RESEARCH, 2017, 23 (24) : 65 - 65
  • [3] Valproic Acid Enhances Venetoclax Efficacy in Targeting Acute Myeloid Leukemia
    Kawakatsu, Renshi
    Tadagaki, Kenjiro
    Yamasaki, Kenta
    Kuwahara, Yasumichi
    Yoshida, Tatsushi
    DISEASES, 2025, 13 (01)
  • [4] PARP Inhibition with Talazoparib Enhances DNA Damage and Anti-Leukemic Activity of Venetoclax in Preclinical Human Acute Myeloid Leukemia (AML) Models
    Giorgi, Marianna
    Portwood, Scott M.
    Boncek, Marina
    Wang, Eunice S.
    BLOOD, 2021, 138
  • [5] PHI-101 synergizes with chemotherapy and venetoclax in preclinical models of acute myeloid leukemia
    Hwang, Hee-sun
    Sung, Gi-Jun
    Kim, Kyung-Ah
    Nam, Ky-Youb
    Kim, Kyu-Tae
    Han, June H.
    Yoon, Jeong-Hyeok
    Nguyen, Bao
    Li, Li
    Seale, Tessa
    Small, Donald
    CANCER RESEARCH, 2024, 84 (06)
  • [6] Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia
    Tahir, Stephen K.
    Calvo, Emiliano
    Carneiro, Benedito A.
    Yuda, Junichiro
    Shreenivas, Aditya
    Jongen-Lavrencic, Mojca
    Gort, Eelke
    Ishizawa, Kenichi
    Morillo, Daniel
    Biesdorf, Carla
    Smith, Morey
    Cheng, Dong
    Motwani, Monica
    Sharon, David
    Uziel, Tamar
    Modi, Dimple A.
    Buchanan, Fritz G.
    Morgan-Lappe, Susan
    Medeiros, Bruno C.
    Phillips, Darren C.
    BLOOD, 2023, 141 (17) : 2114 - 2126
  • [7] Pevonedistat and azacitidine upregulate NOXA (PMAIP1) to increase sensitivity to venetoclax in preclinical models of acute myeloid leukemia
    Cojocari, Dan
    Smith, Brianna N.
    Purkal, Julie J.
    Arrate, Maria P.
    Huska, Jason D.
    Xiao, Yu
    Gorska, Agnieszka
    Hogdal, Leah J.
    Ramsey, Haley E.
    Boghaert, Erwin R.
    Phillips, Darren C.
    Savona, Michael R.
    HAEMATOLOGICA, 2022, 107 (04) : 825 - 835
  • [8] BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid Leukemia
    Ramsey, Haley E.
    Greenwood, Dalton
    Zhang, Susu
    Childress, Merrida
    Arrate, Maria P.
    Gorska, Agnieszka E.
    Fuller, Londa
    Zhao, Yue
    Stengel, Kristy
    Fischer, Melissa A.
    Stubbs, Matthew C.
    Liu, Phillip C. C.
    Boyd, Kelli
    Rathmell, Jeffrey C.
    Hiebert, Scott W.
    Savona, Michael R.
    CLINICAL CANCER RESEARCH, 2021, 27 (02) : 598 - 607
  • [9] Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia
    Daniel A. Luedtke
    Yongwei Su
    Jun Ma
    Xinyu Li
    Steven A. Buck
    Holly Edwards
    Lisa Polin
    Juiwanna Kushner
    Sijana H. Dzinic
    Kathryn White
    Hai Lin
    Jeffrey W. Taub
    Yubin Ge
    Signal Transduction and Targeted Therapy, 5
  • [10] Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia
    Luedtke, Daniel A.
    Su, Yongwei
    Ma, Jun
    Li, Xinyu
    Buck, Steven A.
    Edwards, Holly
    Polin, Lisa
    Kushner, Juiwanna
    Dzinic, Sijana H.
    White, Kathryn
    Lin, Hai
    Taub, Jeffrey W.
    Ge, Yubin
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
12345